Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs
Timo W. M. De Groof, Vladimir Bobkov, Raimond Heukers, et al.
Molecular and Cellular Endocrinology (2019) Vol. 484, pp. 15-24
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Advances in biosensors for the detection of ochratoxin A: Bio-receptors, nanomaterials, and their applications
Yasmin Alhamoud, Danting Yang, Samuel Selorm Fiati Kenston, et al.
Biosensors and Bioelectronics (2019) Vol. 141, pp. 111418-111418
Closed Access | Times Cited: 157
G Protein–Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action
Stacy G. Wendell, Hao Fan, Cheng Zhang
Pharmacological Reviews (2019) Vol. 72, Iss. 1, pp. 1-49
Open Access | Times Cited: 89
Exploring cellular biochemistry with nanobodies
Ross W. Cheloha, Thibault J. Harmand, Charlotte Wijne, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 45, pp. 15307-15327
Open Access | Times Cited: 82
Chemical sensing platforms for detecting trace-level Alzheimer's core biomarkers
Kayoung Kim, Chang Heon Lee, Chan Beum Park
Chemical Society Reviews (2020) Vol. 49, Iss. 15, pp. 5446-5472
Closed Access | Times Cited: 79
Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells
Timo W. M. De Groof, Vida Mashayekhi, Tian Shu Fan, et al.
Molecular Pharmaceutics (2019) Vol. 16, Iss. 7, pp. 3145-3156
Open Access | Times Cited: 74
The CXCL12/CXCR4/ACKR3 Axis in the Tumor Microenvironment: Signaling, Crosstalk, and Therapeutic Targeting
Martine J. Smit, Géraldine Schlecht‐Louf, María Neves, et al.
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 541-563
Open Access | Times Cited: 54
Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies
Timo W. M. De Groof, Elizabeth Elder, Eleanor Y. Lim, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 46
Nanobodies asin vivo, non-invasive, imaging agents
Thibault J. Harmand, Ashraful Islam, Novalia Pishesha, et al.
RSC Chemical Biology (2021) Vol. 2, Iss. 3, pp. 685-701
Open Access | Times Cited: 41
Structure and development of single domain antibodies as modules for therapeutics and diagnostics
Robert J. Hoey, Hyeyoung Eom, James R. Horn
Experimental Biology and Medicine (2019) Vol. 244, Iss. 17, pp. 1568-1576
Open Access | Times Cited: 53
Current status and future expectations of nanobodies in oncology trials
Tessa De Pauw, Lynn De Mey, Jens Debacker, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 8, pp. 705-721
Open Access | Times Cited: 16
Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodies
Timo W. M. De Groof, Nick D. Bergkamp, Raimond Heukers, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 29
NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRET
Jelle van den Bor, Nick D. Bergkamp, Stephanie M. Anbuhl, et al.
Cell Reports Methods (2023) Vol. 3, Iss. 3, pp. 100422-100422
Open Access | Times Cited: 11
Development of a double antibody sandwich ELISA method for the quantitative detection of serum C-reactive protein based on nanobody
Xin Liu, Changjiang Wang, Yu Bai, et al.
Microbial Pathogenesis (2024) Vol. 190, pp. 106615-106615
Closed Access | Times Cited: 4
HDX-MS-optimized approach to characterize nanobodies as tools for biochemical and structural studies of class IB phosphoinositide 3-kinases
Manoj Kumar Rathinaswamy, Kaelin D. Fleming, Udit Dalwadi, et al.
Structure (2021) Vol. 29, Iss. 12, pp. 1371-1381.e6
Open Access | Times Cited: 26
Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy
Cyprine Neba Funeh, Jessica Bridoux, Thomas Ertveldt, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1378-1378
Open Access | Times Cited: 10
Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management
Ying Cong, Nick Devoogdt, Philippe Lambin, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 371-371
Open Access | Times Cited: 3
Monitoring Allosteric Interactions with CXCR4 Using NanoBiT Conjugated Nanobodies
Mark Soave, Raimond Heukers, Barrie Kellam, et al.
Cell chemical biology (2020) Vol. 27, Iss. 10, pp. 1250-1261.e5
Open Access | Times Cited: 25
Nanobodies as Versatile Tool for Multiscale Imaging Modalities
Marco Erreni, Tilo Schorn, Francesca D’Autilia, et al.
Biomolecules (2020) Vol. 10, Iss. 12, pp. 1695-1695
Open Access | Times Cited: 24
Development of a nanobody-based immunoassay for the sensitive detection of fibrinogen-like protein 1
Wanting Zhang, Tingting Liu, Man Wu, et al.
Acta Pharmacologica Sinica (2021) Vol. 42, Iss. 11, pp. 1921-1929
Open Access | Times Cited: 21
Detection of genome‐edited and endogenously expressed G protein‐coupled receptors
Mark Soave, Leigh A. Stoddart, Carl W. White, et al.
FEBS Journal (2021) Vol. 288, Iss. 8, pp. 2585-2601
Open Access | Times Cited: 20
Viral G Protein–Coupled Receptors: Attractive Targets for Herpesvirus-Associated Diseases
Timo W. M. De Groof, Elizabeth Elder, Marco Siderius, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 828-846
Open Access | Times Cited: 18
Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
Yue Chen, Oliver Fleetwood, Sergio Pérez-Conesa, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 12, pp. 6024-6037
Open Access | Times Cited: 17
Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications
Shailendra Kumar Maurya, Parvez Κhan, Asad Ur Rehman, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 914-930
Open Access | Times Cited: 16
Genetically encoded fluorescent biosensors for GPCR research
Hyunbin Kim, In-Yeop Baek, Jihye Seong
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 12
Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor
Raf Van Campenhout, Serge Muyldermans, Mathieu Vinken, et al.
Biomolecules (2021) Vol. 11, Iss. 1, pp. 63-63
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top